Comparative Study of Hop-Containing Products on Human Cytochrome P450-Mediated Metabolism

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 11, 2009, Pages 5100-5105

  Foster, Brian C ^a,b   Kearns, Nikia ^a   Arnason, John T ^a   Saleem, Ammar ^a   Ogrodowczyk, Carolina ^a   Desjardins, Suzanne ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b HEALTH CANADA   (Canada)

Author keywords

Beer; Bitter acids; Cytochrome P450 3A4; Hops; Humulone; Lupulone; P glycoprotein

Indexed keywords

(HEXAHYDRO 5 OXO 1H PYRROLIZINYL 1 YL)ACETIC ACID; (HEXAHYDRO-5-OXO-1H-PYRROLIZINYL-1-YL)ACETIC ACID; ACETIC ACID DERIVATIVE; CYTOCHROME P450; PYRROLIZIDINE ALKALOID;

ARTICLE; BEER; CELL CULTURE; CELL LINE; CHEMISTRY; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLISM; MONOCYTE;

ACETIC ACIDS; BEER; CELL LINE; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; MONOCYTES; PYRROLIZIDINE ALKALOIDS;

CANNABIS; CANNABIS SATIVA; HUMULUS; TRITICUM AESTIVUM;

EID: 67149134946     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf8038132     Document Type: Article

References (24)

1. Fuchs, F. D.; Chambless, L. E. Is the cardioprotective effect of alcohol real?. Alcohol 2007, 41, 399-402.
2. Romeo, J.; Warnberg, J.; Nova, E.; Diaz, L. E.; Gómez-Martinez, S.; Marcos, A. Moderate alcohol consumption and the immune system: a review. Br. J. Nutr. 2007, 98 (Suppl. 1), SI11-SI 15.
3. Bond, C. A.; Raehl, C. L. Adverse drug reactions in United States hospitals. Pharmacotherapy 2006, 26, 601-608.
4. Tanaka, E.; Misawa, S. Pharmacokinetic interactions between acute alcohol ingestion and single doses of benzodiazepines, and tricyclic and tetracydic antidepressants-an update. J. Clin. Pharm. Ther. 1998, 23 (5), 331-336.
5. Hidestrand, M.; Shankar, K.; Ronis, M. J.; Badger, T. M. Effects of light and dark beer on hepatic cylochrome P-450 expression in male rats receiving alcoholic beverages as part of total enteral nutrition. Alcohol: Clin. Exp. Res. 2005, 29, 888-895.
6. Chang, T. K. H.; Chen, J.; Lee, W. B. K. Differential inhibition and inactivation of human CYP1 enzymes by fraw-resveratrol: evidence for mechanism-based inactivation of CYP1A2. J. Pharmacol. Exp. Ther 2001, 299(3), 874-882.
7. Chan, W. K.; Delucchi, A. B. Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4. Life Sci. 2000, 57, 3103-3112.
8. Henderson, M. C.; Miranda, C. L.; Stevens, J. F.; Deinzer, M. L.; Buhler, D. R. In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus. Xenobiotica 2000, 30, 235-251.
9. Monteiro, R.; Becker, H.; Azevedo, I.; Calhau, C. Effect of hop (Humulus lupulus L.) flavonoids on aromatase (estrogen synthase) activity. J. Agric. Food Chem. 2006, 54, 2938-2943.
10. Mannering, G. J.; Shoeman, J. A.; Deloria, L. B. Identification of the antibiotic hops component, colupulone, as an inducer of hepatic cytochrome P-4503A in the mouse. Drug Metab. Dispos. 1992, 20, 142-147.
11. Lemos, C.; Peters, G. J.; Jansen, G.; Martel, F.; Calhau, C. Modulation of folate uptake in cultured human colon adenocarci-noma Caco-2 cells by dietary compounds. Eur. J. Nutr. 2007, 46, 329-336.
12. Jerkovic, V.; Collin, S. Occurrence of resveratrol and piceid in American and European hop cones. J. Agric. Food Chem. 2007, 55, 8754-8758.
13. Foster, B. C.; Foster, M. S.; Vandenhoek, S.; Budzinski, J.; Gallicano, K. D.; Choudri, S.; Krantis, A.; Arnason, J. T. An in vitro evaluation of human cytochrome P450 3A4 and P-glyco-protein inhibition by garlic. J. Pharm. Pharm. Sci. 2001, 4, 159-167.
14. Scott, I. M.; Leduc, R. I.; Burt, A. J.; Maries, R. J.; Arnason, J. T.; Foster, B. C. The inhibition of human cytochrome P450 by ethanol extracts of North American botanicals. Pharm. Bid. 2006, 44 (5), 315-327.
15. Modarai, M.; Gertsch, J.; Suter, A.; Heinrich, M.; Kortenkamp, A. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content. J. Pharm. Pharmacol. 2007, 59, 567-573.
16. Gerhauser, C.; Alt, A. P.; Klimo, K.; Knauft, J.; Frank, N.; Becker, H. Isolation and potential cancer chemopreventive activities of phenolic compounds of beer. Phvtochem. Rev 2002, 1 (3), 369-377.
17. Foster, B. C.; Vandenhoek, S.; Hana, J.; Krantis, A.; Akhtar, M. H.; Bryan, M.; Budzinski, J. W.; Ramputh, A.; Arnason, J. T. In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products. Phytomeclicine 2003, 10, 334-342.
18. Zhou, S.; Gao, Y.; Jiang, W.; Huang, M.; Xu, A.; Paxton, J. P. Interactions of herbs with cytochrome P450. Drug Met. Rev. 2003, 35, 35-98.
19. Huang, S.-M.; Leshko, L. J. Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned?. J. Clin. Pharmacol. 2004, 44, 559-569.
20. Gaudineau, C.; Beckerman, R.; Welbourn, S.; Auclair, K. Inhibition of human P450 enzymes by multiple constituents of the Ginkgo hiloha extract. Biochem. Biophys. Res. Commun. 2004, 318, 1072-1078.
21. Obach, R. S. Inhibition of human cytochrome P450 enzymes by constituents of St. John's wort, an herbal preparation used in the treatment of depression. J. Pharm. Exp. Ther. 2000, 294, 88-95.
22. Schwarz, U. I.; Hanso, H.; Oertel, R.; Miehlke, S.; Kuhlisch, E.; Glaeser, H.; Hitzl, M.; Dresser, G. K.; Kim, R. B.; Kirch, W. Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol. Clin. Pharmacol. Ther. 2007, 81, 669-678.
23. Nowack, R. Review article: Cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: grapefruit juice, St John's wort-and beyond!. Nephrology 2008, 13 (4), 337-347.
24. Marchetti, S.; Mazzanti, R.; Beijnen, J. H.; Schellens, J. H. M. Concise review: Clinical relevance of drug-drug and herb-drug interactions mediated by the ABC transporter ABCB1 (MDR1. P-glycoprotein). Oncologist 2007, 12 (8), 927-941.